Acetylsalicylic acid and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is found among people who take Acetylsalicylic acid, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Acetylsalicylic acid and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 119,478 people who have side effects when taking Acetylsalicylic acid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
119,478 people reported to have side effects when taking Acetylsalicylic acid.
Among them, 37 people (0.03%) have Paranasal sinus hypersecretion.
What is Acetylsalicylic acid?
Acetylsalicylic acid has active ingredients of aspirin. It is often used in high blood pressure. eHealthMe is studying from 119,613 Acetylsalicylic acid users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 704 drugs and 386 conditions by eHealthMe.
Number of Acetylsalicylic acid and Paranasal sinus hypersecretion reports submitted per year:
Gender of people who have Paranasal sinus hypersecretion when taking Acetylsalicylic acid *:
- female: 68.75 %
- male: 31.25 %
Age of people who have Paranasal sinus hypersecretion when taking Acetylsalicylic acid *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 16.13 %
- 60+: 83.87 %
Common drugs people take besides Acetylsalicylic acid *:
- Actemra: 14 people, 37.84%
- Vitamin D3: 14 people, 37.84%
- Vitamin C: 14 people, 37.84%
- Theophylline: 12 people, 32.43%
- Ventolin: 12 people, 32.43%
- Arthrotec: 10 people, 27.03%
- Plavix: 6 people, 16.22%
- Methotrexate: 5 people, 13.51%
- Spiriva: 5 people, 13.51%
- Folic Acid: 5 people, 13.51%
Common side effects people have besides Paranasal sinus hypersecretion *:
- Cough: 26 people, 70.27%
- Fatigue (feeling of tiredness): 21 people, 56.76%
- Joint Pain: 15 people, 40.54%
- Hoarseness Or Changing Voice: 14 people, 37.84%
- Nasopharyngitis (inflammation of the nasopharynx): 12 people, 32.43%
- Sleep Apnea Syndrome: 12 people, 32.43%
- Sinusitis (inflammation of sinus): 12 people, 32.43%
- Lower Respiratory Tract Infection: 11 people, 29.73%
- Body Temperature Increased: 10 people, 27.03%
- Weakness: 9 people, 24.32%
Common conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 22 people, 59.46%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 10.81%
- Cardiac Disorder: 3 people, 8.11%
- Diabetes: 3 people, 8.11%
- Sinus Disorder (disease of sinus): 2 people, 5.41%
- Insomnia (sleeplessness): 2 people, 5.41%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.41%
- High Blood Cholesterol: 2 people, 5.41%
- Headache (pain in head): 2 people, 5.41%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.41%
* Approximation only. Some reports may have incomplete information.
Do you take Acetylsalicylic acid and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of aspirin:
Alternative drugs to, pros and cons of Acetylsalicylic acid:
- Acetylsalicylic acid (119,613 reports)
Common Acetylsalicylic acid side effects:
Browse all side effects of Acetylsalicylic acid:a b c d e f g h i j k l m n o p q r s t u v w x y z
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (4,043 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (704 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (386 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on aspirin (the active ingredients of Acetylsalicylic acid) and Acetylsalicylic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Abreva and Flonase drug interaction - 2 seconds ago
- Hydroxyzine and Blood Potassium Decreased - 4 seconds ago
- Magnesium Sulfate and Toviaz drug interaction - 10 seconds ago
- Buphenyl and Hypertension Aggravated - 19 seconds ago
- Losartan Potassium And Hydrochlorothiazide vs. Valsartan And Hydrochlorothiazide - 21 seconds ago
- Suprax and Allegra D 24 Hour drug interaction - 23 seconds ago
- Affective Disorder and Systemic Lupus Erythematosus - 24 seconds ago
- Carvedilol and Mesenteric Artery Thrombosis - 26 seconds ago
- Detoxification and Drug Screen Positive - 27 seconds ago
- Telmisartan and Albuterol drug interaction - 33 seconds ago